Genomtec S.A. logo

Genomtec S.A. (GMT)

Market Closed
12 Jun, 14:50
WSE WSE
5. 02
+0.04
+0.8032%
- Market Cap
45 P/E Ratio
- Div Yield
10,674 Volume
0.01 Eps
4.98
Previous Close
Add Transaction
Day Range
4.82 5.06
Year Range
3.25 7.33
Want to track GMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GMT closed today higher at zł5.02, an increase of 0.8032% from yesterday's close, completing a monthly increase of 0.4% or zł0.02. Over the past 12 months, GMT stock gained 30.3896%.
GMT is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

GMT Chart

Genomtec S.A. (GMT) FAQ

What is the stock price today?

The current price is zł5.02.

On which exchange is it traded?

Genomtec S.A. is listed on WSE.

What is its stock symbol?

The ticker symbol is GMT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Genomtec S.A. ever had a stock split?

No, there has never been a stock split.

Genomtec S.A. Profile

Biotechnology Industry
Healthcare Sector
Mr. Miron Tokarski Ph.D. CEO
WSE Exchange
PLGNMTC00017 ISIN
DE Country
26 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Clover Corporation Limited is a distinguished entity in the field of manufacturing, refining, and selling tuna oil and encapsulated products with a global footprint that spans Australia, New Zealand, Asia, Europe, and the Americas. Established in 1988, the company has honed its focus towards the development and supply of high-quality docosahexaenoic acid (DHA) tuna oils primarily for the infant formula and pharmaceutical sectors. Operating from its headquarters in Altona North, Australia, Clover Corporation stands as a pioneering force in the nutrition and wellness sector, leveraging advanced technologies and processes to meet the demanding standards of its international clientele.

Products and Services

  • Nu-Mega HiDHA Tuna Oils

    This product line represents Clover Corporation's premium offering of docosahexaenoic acid (DHA) tuna oils, meticulously designed for incorporation into infant formula and various pharmaceutical products. The Nu-Mega HiDHA brand encapsulates the company’s commitment to providing vital nutritional components essential for early development and wellbeing.

  • Ocean Gold Tuna Oils

    The Ocean Gold brand covers a range of cold pressed and refined tuna oils, tailored for applications that demand purity and quality. These oils manifest Clover Corporation’s capability to cater to diverse market needs, extending beyond infant nutrition to encompass broader wellness and dietary supplements.

  • Nu-Mega Driphorm Powders

    Encompassing a versatile range of DHA powders, the Nu-Mega Driphorm series is engineered for integration into a wide array of food applications. This includes infant formula, follow-on formula, growing up milks, and other food applications, offering a flexible solution to enrich products with the nutritional benefits of DHA.

  • Nu-Mega Driphorm HA

    Specifically formulated for non-dairy applications, the Nu-Mega Driphorm HA signifies Clover Corporation’s innovative approach in expanding the accessibility of DHA enrichment to a variety of dietary preferences and restrictions, ensuring the provision of essential nutrients in a more inclusive manner.

  • Microencapsulation Technology

    Clover Corporation’s expertise encompasses not only the production of DHA-rich oils and powders but also advanced microencapsulation technology. This technique enables the effective, stable inclusion of sensitive ingredients in a myriad of products, safeguarding the integrity and efficacy of the nutritional compounds throughout the product lifecycle.

Contact Information

Address: Bierutowska Street 57-59, Wroclaw, Poland, 51-317
Phone: 48 793 440 931